Nektar Therapeutics

Who Is Nektar Therapeutics?

Nektar Therapeutics is a biopharmaceutical company specializing in the development of innovative therapies for autoimmune and inflammatory conditions. The company focuses on harnessing the power of immune science to create treatments that address the root causes of immune dysfunction, aiming to improve patient outcomes by restoring immune health. Nektar's expertise spans foundational scientific research, therapeutic discovery, clinical development, strategic partnerships, and commercialization, all dedicated to advancing treatments for immune-mediated diseases. ([nektar.com](https://www.nektar.com/our-story/?utm_source=openai))

Who Owns Nektar Therapeutics?

Nektar Therapeutics is a publicly traded company listed on the NASDAQ under the ticker symbol NKTR. As a public entity, ownership is distributed among individual and institutional shareholders who hold its publicly available shares. The company's largest shareholders typically include institutional investors such as mutual funds, pension funds, and other financial entities. Specific ownership percentages can fluctuate over time due to market dynamics and trading activities. For the most current information on Nektar's ownership structure, it is advisable to consult the company's investor relations page or financial disclosures. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

When Was Nektar Therapeutics Founded?

Nektar Therapeutics was founded in 1990. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Nektar_Therapeutics?utm_source=openai))

What Services Does Nektar Therapeutics Offer?

Nektar Therapeutics specializes in the discovery and development of novel medicines targeting autoimmune and inflammatory diseases. The company's services include:

• Research and Development: Conducting cutting-edge research to identify and develop new therapeutic candidates.
• Clinical Trials: Designing and executing clinical studies to evaluate the safety and efficacy of investigational drugs.
• Strategic Partnerships: Collaborating with other pharmaceutical companies to advance the development and commercialization of new therapies.
• Regulatory Affairs: Navigating the regulatory landscape to secure approvals for new treatments from health authorities.

Through these services, Nektar aims to bring transformative immune health solutions to patients worldwide. ([nektar.com](https://www.nektar.com/our-story/?utm_source=openai))

Nektar Therapeutics Business Information

Nektar Therapeutics is a biopharmaceutical company headquartered in San Francisco, California. The company focuses on developing therapies for autoimmune and inflammatory conditions, leveraging its expertise in immune science to create treatments that address the underlying causes of immune dysfunction. Nektar's business operations encompass research and development, clinical trials, strategic partnerships, and regulatory affairs, all aimed at bringing innovative therapies to market. ([nektar.com](https://www.nektar.com/our-story/?utm_source=openai))

Nektar Therapeutics Contact

For inquiries or more information about Nektar Therapeutics, you can reach out through the following contact details:

Nektar Therapeutics Phone Number

The main contact number for Nektar Therapeutics is +1 415-482-5300. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Mobile Phone

No mobile phone number could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Fax

No fax number could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Email Address

No email address could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Address

The corporate headquarters of Nektar Therapeutics is located at 455 Mission Bay Blvd S, San Francisco, CA 94158. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Working Hours

Nektar Therapeutics serves during weekday business hours; please get in touch for exact times. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

What Time Does Nektar Therapeutics Open?

Nektar Therapeutics serves during weekday business hours; please get in touch for exact times. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

What Time Does Nektar Therapeutics Close?

Nektar Therapeutics serves during weekday business hours; please get in touch for exact times. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Is Nektar Therapeutics Open on Weekends?

No specific information is available regarding Nektar Therapeutics' weekend hours; please contact the company directly for the most accurate details. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Is Nektar Therapeutics Open on Sundays?

No specific information is available regarding Nektar Therapeutics' Sunday hours; please contact the company directly for the most accurate details. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Instagram

No Instagram account could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Facebook

No Facebook account could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics Twitter (X)

No Twitter account could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))

Nektar Therapeutics LinkedIn

No LinkedIn account could be identified for Nektar Therapeutics; contacting the company directly is recommended for the most up-to-date information. ([stockanalysis.com](https://stockanalysis.com/stocks/nktr/company/?utm_source=openai))